These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37951145)

  • 1. Association between lipid levels and the risk of Parkinson's disease in individuals with diabetes mellitus: A nationwide population-based cohort study.
    Lee HJ; Han K; Kim YW; Yang SN; Yoon SY
    Parkinsonism Relat Disord; 2023 Dec; 117():105881. PubMed ID: 37951145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum cholesterol with Parkinson's disease in a cohort of statin-free individuals.
    Lv Y; Xu B; Zhang X; Chen C; Gao Y; Li N
    Brain Behav; 2022 Jan; 12(1):e2454. PubMed ID: 34894416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
    Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin adherence and the risk of Parkinson's disease: A population-based cohort study.
    Rozani V; Giladi N; El-Ad B; Gurevich T; Tsamir J; Hemo B; Peretz C
    PLoS One; 2017; 12(4):e0175054. PubMed ID: 28388626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Wei Y; Guo H; The E; Che W; Shen J; Hou L; Zhao S; Ye P; Li G; Wang D; Jie Q; Hu D
    Int J Cardiol; 2015 Mar; 182():469-75. PubMed ID: 25612824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
    Huang X; Alonso A; Guo X; Umbach DM; Lichtenstein ML; Ballantyne CM; Mailman RB; Mosley TH; Chen H
    Mov Disord; 2015 Apr; 30(4):552-9. PubMed ID: 25639598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin initiation and risk of incident kidney disease in patients with diabetes.
    Zhou S; Su L; Xu R; Li Y; Chen R; Cao Y; Gao P; Zhang X; Luo F; Gao Q; An S; Cai W; Lin L; Xu H; Liu B; Weng J; Chunbo C; Liu H; Yang Q; Li H; Kong Y; Li G; Wan Q; Zha Y; Hu Y; Xu G; Shi Y; Zhou Y; Su G; Tang Y; Gong M; Xu X; Nie S
    CMAJ; 2023 May; 195(21):E729-E738. PubMed ID: 37247880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus.
    Chang YH; Yen SJ; Chang YH; Wu WJ; Lin KD
    Eur J Neurol; 2021 Feb; 28(2):430-437. PubMed ID: 32969141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
    O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
    Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Khan SU; Rahman H; Okunrintemi V; Riaz H; Khan MS; Sattur S; Kaluski E; Lincoff AM; Martin SS; Blaha MJ
    J Am Heart Assoc; 2019 Apr; 8(7):e011581. PubMed ID: 30898075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term statin use and the risk of Parkinson's disease.
    Friedman B; Lahad A; Dresner Y; Vinker S
    Am J Manag Care; 2013 Aug; 19(8):626-32. PubMed ID: 24304212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease.
    Ndrepepa G; Cassese S; Xhepa E; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
    Am J Cardiol; 2020 Apr; 125(7):1026-1032. PubMed ID: 31955829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China.
    Guo T; Chu C; Wang Y; He M; Jia H; Sun Y; Wang D; Liu Y; Huo Y; Mu J
    BMC Cardiovasc Disord; 2023 Jul; 23(1):337. PubMed ID: 37393236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.
    Steen DL; Khan I; Becker L; Foody JM; Gorcyca K; Sanchez RJ; Giugliano RP
    Clin Cardiol; 2017 Mar; 40(3):155-162. PubMed ID: 28026031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
    Jones PH; Nair R; Thakker KM
    J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.